However, obesity is the fastest-growing segment, with weight management indications driving incremental market expansion
Studies have documented potential effects on visceral adipose tissue (belly fat), subcutaneous fat distribution, and skeletal muscle protein synthesis
In these cases, clinical monitoring every 2 weeks for the first 6 weeks post-cessation is appropriate to catch rebound hyperglycemia in patients with type 2 diabetes or pre-diabetes [13]
The protocol is then constructed to address those priorities in the most clinically efficient sequence
By weeks 2 to 4 at each dose level, your GI system has typically adjusted enough to tolerate moderate, careful drinking
In some studies, tirzepatide has demonstrated greater weight loss compared to other diabetes medications